AC Immune SA is a biopharmaceutical company and a leader in Alzheimer's Disease drug development. AC Immune develops innovative therapeutics with best-in-class potential against Alzheimer's and other diseases caused by misfolding proteins along three axes: vaccines, antibodies and small molecules.

Cooperation possibilities

AC Immune’s expertise and proprietary cutting-edge technologies enable us to support research and enhance the discovery of new molecules. In order to maximize the value of our innovative therapeutics, partnering with leading pharmaceutical companies is a key element of our business strategy.

Location

EPFL Innovation Park, 1015 Lausanne, Switzerland

Facts & figures
  • Type of organization

    Public company

  • Year of foundation

    2003

  • Number of employees in Switzerland

    50-149

Key business